Medicare open enrollment runs through Dec. 7, and changes take effect on Jan. 1, 2027. The Part D annual out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and the temporary Part D premium subsidy ends at year's end. New Medicare-negotiated prices will apply to 15 drugs, including Ozempic, Rybelsus and Wegovy, and CMS expects the change to lower prescription drug coverage for enrollees by $685 million in 2027. The Trump administration also plans one-time $90 payments in October for more than 20 million enrollees to help with Part B premiums, at a cost of about $2 billion, though roughly 35 million Medicare Advantage enrollees are not eligible. Separately, Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on winnipegfreepress.com ↗
Related news
- A new Medicare season begins, but some shifts will arrive in 2027
Open enrollment for Medicare plans runs Thursday through Dec. 7, letting enrollees choose between traditional Medicare, private Medicare Advantage plans and prescription drug plans, with changes effective Jan. 1. In 2027, the annual out-of-pocket cap for Part D drugs rises to $2,400 from $2,100 in 2026, the standard deductible increases from $615 to $700, and the temporary Part D premium subsidy ends. New Medicare-negotiated prices will apply to 15 drugs, including Ozempic, Rybelsus and Wegovy, and CMS expects the change to affect prescription drug coverage by $685 million in 2027. President Donald Trump has also promised one-time $90 payments in October to more than 20 million Medicare enrollees to help cover Part B premiums.
- A new Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment starts Thursday and runs until December 7, as enrollees face changes taking effect in 2027, amid inflation pressure on seniors and midterm elections weeks away. The Part D out-of-pocket cap rises to $2,400 from $2,100 in 2026, the standard deductible increases from $615 to $700, and the temporary Part D premium subsidy ends early. Medicare-negotiated prices for 15 drugs, including Ozempic, Rybelsus and Wegovy, take effect in 2027, and CMS expects this to lower prescription drug coverage for enrollees by $685 million. Social Security benefits will rise 3.6%, or $75 more per month for nearly 72 million recipients, and the increase also translates to extra payments for about 7.3 million SSI beneficiaries. President Trump also announced $90 one-time payments in October for more than 20 million people paying Part B premiums, and roughly 1 million people will receive $500 rebate checks for ACA premiums.
- New Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment begins Thursday and runs until Dec. 7, letting people choose between traditional Medicare, Medicare Advantage and prescription drug plans for coverage starting Jan. 1. Key 2027 changes include a Part D out-of-pocket cap of $2,400 (up from $2,100), a standard deductible rising from $615 to $700, the early end of a temporary Part D premium subsidy, and new negotiated prices for 15 drugs including Ozempic, Rybelsus and Wegovy. Social Security benefits rise 3.6%, about $75 more per month for nearly 72 million recipients. David Lipschutz, co-director of the Center for Medicare Advocacy, warns that some Medicare Advantage plans are leaving areas and cutting benefits such as dental coverage, causing more disruption than usual. President Donald Trump also promised one-time $90 Part B premium payments for more than 20 million enrollees, and $500 rebate checks for about 1 million people on ACA premiums.
- A new Medicare season begins, but some shifts will arrive in 2027
Medicare open enrollment starts Thursday and runs until Dec. 7, letting beneficiaries choose between traditional Medicare, privately run Medicare Advantage plans and prescription drug plans, with changes effective Jan. 1. The Part D out-of-pocket cap will rise to $2,400 from $2,100 in 2026, the standard deductible will increase from $615 to $700, and a temporary Part D premium subsidy will end early. New negotiated prices take effect for 15 drugs, including Ozempic, Wegovy and Rybelsus, and CMS expects the change to lower prescription drug costs for enrollees by $685 million in 2027. Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients. Trump also promised one-time $90 payments to more than 20 million Medicare enrollees, costing about $2 billion.
- A new Medicare season begins, but some shifts will arrive in 2027
Medicare open enrollment starts Thursday and runs until Dec. 7, letting people choose between traditional Medicare, Medicare Advantage and prescription drug plans, with changes effective Jan. 1, 2027. The Part D out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and a temporary Part D premium subsidy will end early. Medicare-negotiated prices take effect for 15 drugs, including Ozempic, Rybelsus and Wegovy, with CMS estimating a $685 million impact on prescription drug coverage in 2027. A 3.6% Social Security cost-of-living increase adds about $75 a month for nearly 72 million beneficiaries. The Trump administration also promised one-time $90 payments in October to more than 20 million Medicare enrollees at a cost of about $2 billion, though roughly 35 million Medicare Advantage enrollees are not eligible.
- A new Medicare season begins , but some shifts will arrive in 2027
Related markets
Latest news
- Meta Earnings: What To Look For From META
Meta Platforms (NASDAQ:META) will report earnings this Wednesday after the market closes. Last quarter, revenue reached $60.8 billion, up 28% year on year and above analysts' expectations, though revenue guidance for next quarter slightly missed forecasts; daily active users hit 3.6 billion, up 3.4%. The market expects revenue growth of 23.6% this quarter, slowing from 26.2% a year earlier, and analysts have generally reconfirmed their estimates over the past 30 days. Over the last month, consumer internet stocks have gained 1.3% on average, while Meta is down 4.8%.
- An AI bust could come from places investors arent watching , an economist says
Concerns about an AI bubble are growing, and TS Lombard's Dario Perkins warns that investors may be overlooking other risks. Debt among smaller cloud providers, model developers and suppliers could reach $2 trillion by the end of 2027. Perkins does not see this as a systemic risk, but warns that earnings disappointments and canceled orders could ripple through the ecosystem, and that a chip glut could follow over-ordering. Much of the industry's revenue growth still comes from spending within the AI ecosystem rather than from businesses and consumers outside it. He also flags political backlash, noting that ordinary people dislike AI and nearby datacenters, and warns that one high-profile accident could turn AI toxic.
- Yen jumps after JGB auction draws big demand , euro finds relief
The yen rose 0.2% to 158.15 per dollar in Asian trading after a 20-year Japanese government bond auction drew bids of 5.84 times the amount sold, well above the 4.01 times at the previous auction, and the yield fell 6 basis points to 3.71%. A State Street strategist said the record demand suggests sidelined cash is returning and that JGBs are becoming a relative haven from political and fiscal volatility in Europe, particularly France. Anti-government protests in France prompted curfews in several cities, while Italy said it would send 500 troops after two days of unrest, and the euro rallied 0.2% to $1.1234. Elsewhere, bitcoin slipped 0.3% to $81,674.25 and ether edged down 0.2% to $2,393.21.
- Unemployment rate dips to 4 . 7 % - but vacancies hit five - year low
Vacancies fell by 21,000 to 691,000 in the three months to September, the biggest drop since the three months to March and the lowest since July to September 2014 outside the pandemic, while unemployment dipped in the three months to August. Payroll numbers were down 66,000 over the year to September. The ONS said the fall was mainly among smaller firms struggling with higher labour costs, following rises in employer national insurance, the minimum wage and workers' rights. A CBI survey found labour costs and regulations were making it harder to create jobs, and firms urged the Chancellor not to add to their burden in the October 28 Budget. ICAEW's Suren Thiru said the labour market is 'running on idle' and unemployment could climb above 5 per cent, while Shadow Chancellor Andrew Griffith blamed Labour's 'Jobs Tax' and red tape.
- CNBC Daily Open: Tech rebounds in the U.S., but Asia isn’t buying it yet
U.S. tech stocks rebounded as the Nasdaq Composite rose more than 1% on Monday, with Nvidia up 1.4% and Tesla up 3.8%. In Asia, however, tech shares fell on Tuesday, with South Korea's Kospi down over 4% and Japan's Nikkei 225 down 1.6%. Nvidia also unveiled plans to back four German AI startups as part of its nearly $10 billion European investment commitment. Jenny Lee of Granite Asia said Asian companies are reaching IPOs much sooner, often at four to five years old, while Jio Platforms' Indian IPO saw its anchor investor quota oversubscribed more than 30 times, aiming to raise up to 302 billion rupees ($3.2 billion). In Singapore, several agricultural stocks fell after Senior Minister K Shanmugam warned that companies would not escape responsibility for possible roles in the haze, noting seven firms had been questioned by the Singapore Exchange.
- NiSource (NI) Stock Looks Overvalued Against Its Dividend Outlook
NiSource has nearly doubled shareholders' money over the past five years, delivering a 97.6% total return, which raises the question of whether dividends can justify the current share price. The article highlights a new 20-year energy agreement with Microsoft, including customer-funded grid upgrades and long-term electric service for data centers, which may affect future capital needs and cash-flow visibility. Using a Dividend Discount Model with inputs of about $1.35 dividend per share, roughly 9.07% return on equity, a payout ratio slightly above 61%, and implied dividend growth of about 3.5%, the estimated intrinsic value sits meaningfully below the current share price of $41.95. The model still does not bridge that gap, suggesting income investors are paying a premium for a relatively steady payout with modest assumed growth.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.